Nutshell Therapeutics
PrivateLast Round
Series A
Extension
Mar 14, 2022
Total Funding Raised
$60M
Company Overview
Nutshell Therapeutics is a biotechnology company that develops small molecule drugs for challenging targets using its proprietary AI-driven allosteric drug discovery platform, AlloStar.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutshell Therapeutics Comparables
Compare Nutshell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atavistik Bio | 85% | |
| HotSpot Therapeutics | 82% | |
| UCDOM BioTech (Shanghai) Co., Ltd. | 79% |
Nutshell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 14, 2022 | ||||
| Series A | Jan 13, 2022 | ||||
| VC Round | Sep 6, 2015 |
Key People
Founding team and executive leadership
Nutshell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baidu Ventures | Series A |
| Northern Light Venture Capital | Series A |
| MPC | Series A |
| Source Code Capital | Series A |
| Genesis Capital | Series A Extension |
| Kunlun Capital | Series A |
| Straylight Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 14, 2022
$40M round led by Genesis Capital.
Nutshell Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nutshell Therapeutics's valuation, stock price, and market status.
Is NUTSHELL a public or private company?
NUTSHELL is a private company.
What is the current stock price of NUTSHELL?
NUTSHELL is a private company with no public stock price. No recent secondary market data is available.
How much is NUTSHELL worth (valuation)?
Valuation information for NUTSHELL is not publicly available.
Can I buy NUTSHELL stock?
NUTSHELL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NUTSHELL's last funding round?
NUTSHELL's most recent funding round was VC Round on September 6, 2015.
Who are the main investors in NUTSHELL?
Key investors in NUTSHELL include Straylight Capital.
Will NUTSHELL IPO soon?
No public IPO plans have been announced for NUTSHELL.
How can I track NUTSHELL secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NUTSHELL's secondary market activity and sign up for updates.